Buy Semaglutide in San Francisco — $99/Month | Trimi Health
GLP-1 weight loss treatment in San Francisco — shipped directly to your Bay Area address in 2–3 business days. No clinic visits, no insurance required, just $99/month for compounded semaglutide.
More on GLP-1 by Location
Why San Francisco Residents Choose Telehealth for GLP-1
San Francisco is one of the most expensive cities in America, and its healthcare market reflects that premium. Weight loss clinics in Pacific Heights, the Marina, and SOMA routinely charge $400–700 per month for compounded semaglutide — significantly above the national average. For a city where the median rent exceeds $3,000/month, adding $500+ for weight loss medication is a significant burden.
The Bay Area's tech-forward culture has made San Francisco one of the leading adopters of telehealth nationally. San Francisco residents are accustomed to digital-first healthcare experiences, making telehealth GLP-1 programs a natural fit. Trimi delivers compounded semaglutide for $99/month — a fraction of what local clinics charge.
San Francisco GLP-1 Snapshot
Population: ~870,000 city / ~4.7 million Bay Area. Typical clinic cost: $400–700/mo. Brand Wegovy: $1,000–$1,400/mo. Trimi telehealth: $99/mo semaglutide, $125/mo tirzepatide.
Learn more about how telehealth prescribing works. You can also read about Ozempic vs. Wegovy or explore our GLP-1 beginner guide.
San Francisco Pricing: Trimi vs Local Providers & Pharmacies
| Option | Monthly Cost | In-Person Visit | Insurance Required |
|---|---|---|---|
| SF Weight Loss Clinic (avg) | $400–$700 | Yes | Sometimes |
| SF Pharmacy (brand Wegovy) | $1,000–$1,400 | Yes | Recommended |
| Trimi Telehealth (compounded) | $99/mo (sema) / $125/mo (tirz) | No | No |
Read our semaglutide vs. tirzepatide comparison to find the right medication for you.
How It Works: 3 Steps to Get Semaglutide in San Francisco
Step 1: Online Health Intake
Complete a health questionnaire covering your medical history, medications, BMI, and goals — from anywhere in San Francisco or the Bay Area.
Step 2: Provider Review & Prescription
A licensed California provider evaluates your submission, confirms GLP-1 candidacy, and sends your prescription to a licensed compounding pharmacy.
Step 3: Delivered to Your SF Door
Temperature-controlled packaging arrives at your San Francisco address within 3–5 business days. Monthly refills ship automatically.
Check our GLP-1 candidacy guide to see if you qualify.
Available Medications for San Francisco Residents
Compounded Semaglutide
$99/month
- Same active ingredient as Wegovy
- Weekly self-injection
- ~15% average weight loss at 68 weeks
- No insurance required
Compounded Tirzepatide
$125/month
- Dual GLP-1/GIP receptor agonist
- Weekly self-injection
- ~22% average weight loss at 72 weeks
- No insurance required
Learn about compounded medication safety and explore our GLP-1 weight loss timeline to set realistic expectations.
Getting Started with Trimi in San Francisco
San Francisco residents with a BMI of 27+ (with a weight-related condition) or 30+ may qualify for GLP-1 treatment. Whether you're in the Castro, Richmond District, Daly City, or anywhere in the Bay Area, Trimi ships directly to your door.
Explore our first month on semaglutide guide, learn about managing GLP-1 side effects, or see diet tips while on semaglutide.
Ready to Start in San Francisco?
Get compounded semaglutide delivered to any San Francisco address for $99/month. No office visit, no insurance, no waiting room.
Get Started for $99/MonthFrequently Asked Questions: Semaglutide in San Francisco
Can I get semaglutide in San Francisco without visiting a clinic?
Yes. Trimi offers compounded semaglutide entirely through telehealth. San Francisco residents complete an online health intake, receive a provider evaluation, and get medication shipped directly to their San Francisco address — no in-person visit required.
How much does semaglutide cost at San Francisco weight loss clinics?
San Francisco-area weight loss clinics in neighborhoods like Pacific Heights, the Marina, and SOMA typically charge $400–700 per month for compounded semaglutide programs — reflecting the city's higher cost of living. Trimi delivers the same compounded semaglutide for $99/month.
How fast is shipping to San Francisco?
Most San Francisco residents receive their compounded semaglutide within 3–5 business days after prescription approval. Medication ships to your San Francisco address — whether you're in the Mission, Sunset, or across the Bay in Oakland.
Is telehealth prescribing legal in California?
Yes. California has some of the most progressive telehealth laws in the country, permitting licensed providers to conduct evaluations and prescribe medications including GLP-1 agonists entirely online. Trimi connects San Francisco residents with licensed providers.
Does Trimi offer tirzepatide as well as semaglutide in San Francisco?
Yes. Trimi offers both compounded semaglutide at $99/month and compounded tirzepatide at $125/month for San Francisco and Bay Area residents. A licensed provider will help determine which medication best fits your health goals.
What makes San Francisco unique for GLP-1 access?
San Francisco's high cost of living extends to healthcare. Weight loss clinics in the city charge among the highest rates in the country. Telehealth at $99/month makes GLP-1 treatment accessible regardless of neighborhood, from the Tenderloin to Pacific Heights.
Can I continue treatment if I move within the Bay Area?
Yes. Because Trimi is a telehealth program, your care is tied to your account. Whether you move from San Francisco to San Jose, Berkeley, or anywhere in the Bay Area, your treatment continues without interruption.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Semaglutide and tirzepatide are prescription medications requiring evaluation by a licensed healthcare provider. Individual results vary. Common side effects include nausea, vomiting, diarrhea, and constipation. Not appropriate for individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- San Francisco Department of Public Health. Community Health Assessment 2023.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).